期刊論文1. | McClellan, J. M.、Susser, E.、King, M. C.(2007)。Schizophrenia: a common disease caused by multiple rare alleles。Br J Psychiatry,190,194-199。 |
2. | Chung, Wen-Hung、Hung, Shuen-Iu、Hong, Hong-Shang、Hsih, Mo-Song、Yang, Li-Cheng、Ho, Hsin-Chun、Wu, Jer-Yuarn、Chen, Yuan-Tsong(2004)。Medical Genetics: A Marker for Stevens-Johnson Syndrome。Nature,428(6982)。 |
3. | Dalmau, J.、Tüzūn, E.、Wu, H. Y.(2007)。Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma。Ann Neurol,61,25-36。 |
4. | Vitaliani, R.、Mason, W.、Ances, B.、Zwerdling, T.、Jiang, Z.、Dalmau, J.(2005)。Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma。Ann Neurol,58,594-604。 |
5. | Moraes, F.、Goes, A.(2016)。A decade of human genome project conclusion: scientific diffusion about our genome knowledge。Biochem Mol Biol Educ,44,215-223。 |
6. | Manolio, T. A.、Abramowicz, M.、Al-Mulla, F.(2015)。Global implementation of genomic medicine: we are not alone。Sci Transl Med,7(290)。 |
7. | Wilson, B. J.、Nicholls, S. G.(2015)。The Human Genome Project, and recent advances in personalized genomics。Risk Manag Healthc Policy,8,9-20。 |
8. | Collins, F. S.、Varmus, H.(2015)。A new initiative on precision medicine。N Engl J Med,372,793-795。 |
9. | Scull, A.(2010)。A psychiatric revolution。Lancet,375(9722),1246-1247。 |
10. | Coyle, J. T.(1996)。Molecules and mind: a new home for molecular research in psychiatry。Mol Psychiatry,1,5-6。 |
11. | Licinio, J.(2011)。Translational psychiatry: leading the transition from the cesspool of devastation to a place where the grass is really greener。Transl Psychiatry,1。 |
12. | Insel, T. R.(2011)。A bridge to somewhere。Transl Psychiatry,1。 |
13. | Berger, J. R.、Dean, D.(2014)。Neurosyphilis。Handb Clin Neurol,121,1461-1472。 |
14. | Yanhua, W.、Haishan, S.、Le, H.(2016)。Clinical and neuropsychological characteristics of general paresis misdiagnosed as primary psychiatric disease。BMC Psychiatry,16。 |
15. | Lin, J. J.、Lin, K. L.、Hsia, S. H.(2014)。Anti-N-methyl-D-aspartate receptor encephalitis in Taiwan--a comparison between children and adults。Pediatr Neurol,50,574-580。 |
16. | Preskorn, S. H.(2016)。Personalized medicine in psychiatry: concepts for bringing associated testing into clinical practice。Mayo Clin Proc,91,827-829。 |
17. | Leypoldt, F.、Armangue, T.、Dalmau, J.(2015)。Autoimmune encephalopathies。Ann NY Acad Sci,1338,94-114。 |
18. | Barry, H.、Hardiman, O.、Healy, D. G.(2011)。Anti-NMDA receptor encephalitis: an important differential diagnosis in psychosis。Br J Psychiatry,199,508-509。 |
19. | Barry, H.、Byrne, S.、Barrett, E.、Murphy, K. C.、Cotter, D. R.(2015)。Anti-N-methyl-d-aspartate receptor encephalitis: review of clinical presentation, diagnosis and treatment。BJPsych Bull,39,19-23。 |
20. | Chapman, M. R.、Vause, H. E.(2011)。Anti-NMDA receptor encephalitis: diagnosis, psychiatric presentation, and treatment。Am J Psychiatry,168,245-251。 |
21. | Dowben, J. S.、Kowalski, P. C.、Keltner, N. L.(2015)。Biological perspectives: anti-NMDA receptor encephalitis。Perspect Psychiatr Care,51,236-240。 |
22. | Chang, H. S.、Chen, P. M.、Lu, T.、Hu, L. Y.(2015)。Anti-N-methyl- D-aspartate receptor encephalitis: should psychiatrists shoulder the responsibility for a non-psychiatric disorder?。J Neurol Sci,353,189-190。 |
23. | Pollak, T. A.、Beck, K.、Irani, S. R.、Howes, O. D.、David, A. S.、McGuire, P. K.(2016)。Autoantibodies to central nervous system neuronal surface antigens: psychiatric symptoms and psychopharmacological implications。Psychopharmacology (Berl),233,1605-1621。 |
24. | Chefdeville, A.、Honnorat, J.、Hampe, C. S.、Desestret, V.(2016)。Neuronal CNS syndromes likely mediated by auto-antibodies。Eur J Neurosci,43,1535-1552。 |
25. | Crisp, S. J.、Kullmann, D. M.、Vincent, A.(2016)。Autoimmune synaptopathies。Nat Rev Neurosci,17,103-117。 |
26. | Linnoila, J. J.、Rosenfeld, M. R.、Dalmau, J.(2014)。Neuronal surface antibody-mediated autoimmune encephalitis。Semin Neurol,34,458-466。 |
27. | Titulaer, M. J.、McCracken, L.、Gabilondo, I.(2013)。Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study。Lancet Neurol,12,157-165。 |
28. | Graus, F.、Titulaer, M. J.、Balu, R.、Benseler, S.、Bien, C. G.、Cellucci, T.、Cortese, I.、Dale, R. C.、Gelfand, J. M.、Geschwind, M.、Glaser, C. A.、Honnorat, J.、Höftberger, R.、Iizuka, T.、Irani, S. R.、Lancaster, E.、Leypoldt, F.、Prüss, H.、Rae-Grant, A.、Dalmau, J.(2016)。A clinical approach to diagnosis of autoimmune encephalitis。The Lancet Neurology,15(4),391-404。 |
29. | Lancaster, E.(2016)。The diagnosis and treatment of autoimmune encephalitis。J Clin Neurol,12,1-13。 |
30. | Psychiatric, GWAS Consortium Coordinating Committee、Cichon, S.、Craddock, N.(2009)。Genomewide association studies: history, rationale, and prospects for psychiatric disorders。Am J Psychiatry,166,540-556。 |
31. | Psychiatric GCSC(2009)。A framework for interpreting genome-wide association studies of psychiatric disorders。Mol Psychiatry,14(1),10-17。 |
32. | Schizophrenia Working Group of the Psychiatric Genomics Consortium(2014)。Biological insights from 108 schizophrenia-associated genetic loci。Nature,511,421-427。 |
33. | Dima, D.、Breen, G.(2015)。Polygenic risk scores in imaging genetics: usefulness and applications。J Psychopharmacol,29,867-871。 |
34. | Santoro, M. L.、Moretti, P. N.、Pellegrino, R.(2016)。A current snapshot of common genomic variants contribution in psychiatric disorders。American Journal of Medical Genetics Part B: Neuropsychiatric Genetics,171(8),997-1005。 |
35. | Iyegbe, C.、Campbell, D.、Butler, A.、Ajnakina, O.、Sham, P.(2014)。The emerging molecular architecture of schizophrenia, polygenic risk scores and the clinical implications for GxE research。Soc Psychiatry Psychiatr Epidemiol,49,169-12。 |
36. | Uher, R.(2009)。The role of genetic variation in the causation of mental illness: an evolution-informed framework。Mol Psychiatry,14,1072-1082。 |
37. | Miller, D. T.、Adam, M. P.、Aradhya, S.(2010)。Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies。Am J Hum Genet,86,749-764。 |
38. | Battaglia, A.、Doccini, V.、Bernardini, L.(2013)。Confirmation of chromosomal microarray as a first-tier clinical diagnostic test for individuals with developmental delay, intellectual disability, autism spectrum disorders and dysmorphic features。Eur J Paediatr Neurol,17,589-599。 |
39. | Georgieva, L.、Rees, E.、Moran, J. L.(2014)。De novo CNVs in bipolar affective disorder and schizophrenia。Hum Mol Genet,23,6677-6683。 |
40. | Gershon, E. S.、Alliey-Rodriguez, N.(2013)。New ethical issues for genetic counseling in common mental disorders。Am J Psychiatry,170,968-976。 |
41. | Schreiber, M.、Dorschner, M.、Tsuang, D.(2013)。Next-generation sequencing in schizophrenia and other neuropsychiatric disorders。American Journal of Medical Genetics Part B: Neuropsychiatric Genetics,162(7),671-678。 |
42. | Kato, T.(2015)。Whole genome/exome sequencing in mood and psychotic disorders。Psychiatry Clin Neurosci,69,65-76。 |
43. | Buxbaum, J. D.、Daly, M. J.、Devlin, B.(2012)。The autism sequencing consortium: large-scale, high-throughput sequencing in autism spectrum disorders。Neuron,76,1052-1056。 |
44. | Sener, E. F.、Canatan, H.、Ozkul, Y.(2016)。Recent advances in autism spectrum disorders: applications of whole exome sequencing technology。Psychiatry Investig,13,255-264。 |
45. | Shinozaki, G.、Potash, J. B.(2014)。New developments in the genetics of bipolar disorder。Curr Psychiatry Rep,16。 |
46. | Gelernter, J.(2015)。Genetics of complex traits in psychiatry。Biol Psychiatry,77,36-42。 |
47. | Nassan, M.、Nicholson, W. T.、Elliott, M. A.、Rohrer Vitek, C. R.、Black, J. L.、Frye, M. A.(2016)。Pharmacokinetic pharmacogenetic prescribing guidelines for antidepressants: a template for psychiatric precision medicine。Mayo Clin Proc,91,897-907。 |
48. | Oedegaard, K. J.、Alda, M.、Anand, A.(2016)。The Pharmacogenomics of Bipolar Disorder study (PGBD): identification of genes for lithium response in a prospective sample。BMC Psychiatry,16。 |
49. | Hou, L.、Heilbronner, U.、Degenhardt, F.(2016)。Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study。Lancet,387,1085-1093。 |
50. | Fabbri, C.、Crisafulli, C.、Calabrò, M.、Spina, E.、Serretti, A.(2016)。Progress and prospects in pharmacogenetics of antidepressant drugs。Expert Opinion on Drug Metabolism & Toxicology,12(10),1157-1168。 |
51. | 李敏秀(20160600)。Pharmacogenetics of Antidepressants: Is There a Magic Bullet for Treating Depression?。Taiwanese Journal of Psychiatry,30(2),79-90+a6。 |
52. | Koga, A. T.、Strauss, J.、Zai, C.、Remington, G.、De Luca, V.(2016)。Genome-wide association analysis to predict optimal antipsychotic dosage in schizophrenia: a pilot study。J Neural Transm,123,329-338。 |
53. | Sriretnakumar, V.、Huang, E.、Muller, D. J.(2015)。Pharmacogenetics of clozapine treatment response and side-effects in schizophrenia: an update。Expert Opin Drug Metab Toxicol,11,1709-1731。 |
54. | Biernacka, J. M.、Sangkuhl, K.、Jenkins, G.(2015)。The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response。Transl Psychiatry,5。 |